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Abstract
Tissue engineering sustains the need of a three-dimensional (3D) scaffold to promote the
regeneration of tissues in volume. Usually, scaffolds are seeded with an adequate cell population,
allowing their growth and maturation upon implantation in vivo. Previous studies obtained by our
group evidenced significant growth patterns and osteogenic differentiation of human bone marrow
mesenchymal stem cells (hBMSCs) when seeded and cultured on melt-based porous chitosan
fibre mesh scaffolds (cell constructs). Therefore, it is crucial to test the in vivo performance of
these in vitro 3D cell constructs. In this study, chitosan-based scaffolds were seeded and cultured
in vitro with hBMSCs for 3 weeks under osteogenic stimulation conditions and analysed for cell
adhesion, proliferation and differentiation. Implantation of 2 weeks precultured cell constructs in
osteogenic culture conditions was performed into critical cranial size defects in nude mice. The
objective of this study was to verify the scaffold integration and new bone formation. At 8 weeks
of implantation, scaffolds were harvested and prepared for micro-computed tomography (µCT)
analysis. Retrieved implants showed good integration with the surrounding tissue and significant
bone formation, more evident for the scaffolds cultured and implanted with human cells. The results
of this work demonstrated that chitosan-based scaffolds, besides supporting in vitro proliferation
and osteogenic differentiation of hBMSCs, induced bone formation in vivo. Thus, their osteogenic
potential in orthotopic location in immunodeficient mice was validated, evidencing good prospects
for their use in bone tissue-engineering therapies. Copyright  2011 John Wiley & Sons, Ltd.
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1. Introduction
Tissue engineering has emerged in the last 17 years as a
new regenerative approach for the treatment of a variety
of tissues, including bone. The concept is based on the
development of strategies aimed at obtaining tissue and
organ equivalents that can replace or restore the natu-
ral features and physiological functions of natural tissues
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in vivo (Langer and Vacanti, 1993). One of the fundamen-
tal principles relies on the need of a specific cell population
in combination with a 3D structure, in order to promote,
in volume, tissue regeneration (Hutmacher et al., 2007).
The ideal cell population is considered to be autologous
undifferentiated stem cells that can be isolated from
adult sources. Although embryonic stem cells display an
enormous potential, they raise ethical and moral issues,
mainly because of the removal and destruction of human
embryos (Hipp and Atala, 2008). In this context, adult
stem cells present an alternative option, being isolated
from several sources, such as bone marrow (Bianco and
Robey, 2001), brain, liver, skin, skeletal muscle, intestine,
pancreas, peripheral blood, dental pulp (Hipp and Atala,
2008), adipose tissue (Gimble and Guilak, 2003) or fetal
tissues such as umbilical cord (Sarugaser et al., 2005)
or amniotic fluid. Stem cells are defined as cells that
have clonogenic and self-renewing capabilities and that
differentiate intomultiple cell lineages (Weissman, 2000).
Mesenchymal stem cells (MSCs) can be combined with
appropriate carriers (scaffolds) where a cell population
will be grown and further implanted in vivo. Scaffolds
used for tissue-engineering purposes mimic the extracel-
lular matrix (ECM) of the regenerating bone environment.
Selection of the material for scaffold production in bone-
related applications is a very important step towards the
creation of a tissue-engineered construct (Martins et al.,
2009).
In recent years, natural polymers emerged as an
alternative to synthetic polymers, mainly due to their
biocompatibility and biodegradability. Most of the
synthetic biomaterials are effective in supporting bone
regeneration, either alone or in conjunction with growth
factors, although they display limitations. Ideally this
structure should be biodegradable, allowing cells to
adhere and proliferate, leading to the formation of ECM
(Salgado et al., 2004). Different naturally based polymers
have been proposed for this demanding application, such
as starch (Gomes et al., 2001; Salgado et al., 2002)
and chitosan (Costa-Pinto et al., 2008, 2009; Malafaya
et al., 2005; Martins et al., 2008). Chitosan has shown
an excellent combination of properties, including non-
antigenicity and non-cytotoxicity, making this biomaterial
quite attractive for bone tissue-engineering applications
(Di Martino et al., 2005; Zarzycki and Modrzejewska,
2003).
We have developed a set of biomaterials using the
thermal-based processing of thermoplastic polymers, by
blending chitosan (Ch) with different aliphatic polyesters,
such as poly(caprolactone) (PCL), poly(butylene succi-
nate) (PBS), poly(butylene terephthalate adipate) (PBTA)
and poly(butylene succinate adipate) (PBSA) (Correlo
et al., 2005, 2009). After testing the eventual cytotoxi-
city of the developed scaffolds, the next step consisted
of the biological screening of the most suitable scaffold
formulation for bone tissue-engineering applications. For
that, we tested several blends with a mouse mesenchymal
stem cell line (BMC9), promoting differentiation into the
osteogenic lineage. The results evidenced that the chi-
tosan–PBS blend formulation, 50% wt and 60% porosity,
showed the best performance in terms of cell behaviour
(Costa-Pinto et al., 2008). Further studies were performed
using human bone marrow mesenchymal stem cells
(hBMSCs) in fibre-mesh scaffold morphology, with excel-
lent results in terms of cell adhesion, proliferation and
osteogenic differentiation (Costa-Pinto et al., 2009). Also,
osteogenic differentiation of these cells onto the scaffolds
was consistently detected by the presence of mineralized
ECM (Gupta et al., 2008; Wu et al., 2010). Therefore, the
fibrous morphology enhanced conditions to promote cell
infiltration into the inner regions of the scaffold.
Thus, the next step is to evaluate this tissue-engineering
strategy in vivo, using a feasible animal model. For that,
we have selected the cranial defect in nude mice (An and
Freidman, 1998; Schmitz and Hollinger, 1986), since it
enables several aspects of this strategy to be tested. The
calvaria form a flat bone, which allows the creation of a
uniform circular defect with an adequate size for easier
surgical procedure and specimen handling. Fixation is
provided by the dura mater and the overlying skin. The
model has been thoroughly used and studied and is
well reproduced (An and Freidman, 1998; Montjovent
et al., 2007; Schmitz and Hollinger, 1986). The low
vascularization in cranial area turns this model into one of
the toughest to evaluate the in vivo performance of tissue-
engineered constructs (Castano-Izquierdo et al., 2007).
The nude mouse model is required, since human cells
will be implanted, avoiding graft rejection responses from
the host (Gupta et al., 2008). The critical size defect
(CSD) for this model is 4–5 mm. A CSD is defined as
the intraosseous wound in a specific bone and species of
animal without spontaneous healing during the lifetime
of the animal (Wu et al., 2010).
Herein, we have selected compression-moulded salt-
leaching scaffolds. We considered this production method
to be the most appropriate for the development of scaf-
folds that meet the required dimensions to fit into the
animal calvaria defect. In the present study, we have
assessed the in vitro biological behaviour of hBMSCs
cultured on chitosan–PBS scaffolds, and these 3D cell
constructs were validated in an in vivo model of a critical
cranial defect in nude mice.
2. Materials and methods
2.1. Production of scaffolds
The scaffolds used in this study were produced by melt-
based compression moulding followed by salt leaching.
Briefly, chitosan was melt-blended with PBS (50% in
weight) by extrusion and further ground into a powder.
This powder was subjected to solid mixing with salt par-
ticles in the size range 250–500 µm and a salt content of
60%. Details of the processing methodology can be found
elsewhere (Correlo et al., 2009).
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2.2. Characterization of scaffolds
Cross-sections of all the developed scaffolds were anal-
ysed using a Leica-Cambridge S-360 scanning electron
microscope (SEM) for preliminary assessment on their
morphology. All the samples were sputter-coated with
gold prior to the SEM analysis.
To evaluate the internal 3D structure of the scaffolds,
micro-computed tomography (µCT) equipment (SkyScan,
Belgium) was used as a non-destructive characterization
methodology. Three scaffolds were scanned in high-
resolution mode of 8.7 µm x/y/z and an exposure time
of 1792 ms. The scanner energy was set to 63 keV with
157 µA current. µCT scans followed by 3D reconstruction
(µCT analyser and a µCT volume realistic 3D visualiza-
tion, from SkyScan) of serial image sections allowed the
reconstruction and analysis of the 3Dmicroarchitecture of
the scaffolds, pore morphology, determination of porosity
and interconnectivity.
2.3. In vitro cell culture
Human bone marrow mesenchymal stem cells (hBMSCs)
were isolated from bone marrow and characterized for
the MSC phenotype (Delorme and Charbord, 2007). Cells
were expanded in α-minimum essential medium (α-MEM;
Sigma, St. Louis, MO, USA) with 10% fetal bovine serum
(FBS; Biochrom AG, Germany), 1 ng/ml basic fibroblast
growth factor (bFGF; PeproTech, USA) and 1% antibi-
otic/antimycotic mixture (Sigma). When a sufficient cell
number was obtained, cells at passage 2 were seeded onto
scaffolds at a density of 2.5× 105 cells/scaffold. After 24 h
of attachment, cell constructs were placed in new 24-well
plates and 1 ml osteogenic medium containing dexam-
ethasone 10−8 M (Sigma), ascorbic acid 50 µg/ml (Sigma)
and β-glycerophosphate 10 mM (Sigma) was added to
each well. The cell constructs were cultured for 7, 14 and
21 days in a humidified atmosphere at 37 ◦C containing
5% CO2.
2.3.1. Cell adhesion and morphology
by scanning electron microscopy (SEM)
Cell adhesion, morphology and distribution throughout
the scaffolds were analysed by SEM. Cell constructs
were fixed and dehydrated using a sequence of ethanol
gradients and further sputter-coated with gold (JEOL JFC-
1100) for analysis, using a Leica Cambridge S360 SEM.
2.3.2. Cell viability assay –MTS test
Cell viability was assessed after 3 h, 7, 14 and 21 days
using the MTS test. Cell constructs (n = 3) were washed
in phosphate-buffered saline (PBS; Sigma), immersed in
a mixture consisting of serum-free cell culture medium
and MTS reagent in a 5:1 ratio and incubated for 3 h
at 37 ◦C in a humidified atmosphere containing 5% CO2.
Scaffolds alone, incubated for the same time in osteogenic
medium, were used as controls. After this, 200 µl (n = 3)
were transferred to 96-well plates and the optical den-
sity (OD) was measured on a microplate ELISA reader
(BioTek, USA), using an absorbance of 490 nm.
2.3.3. Alkaline phosphatase (ALP) quantification
Samples were washed with phosphate buffered saline
solution and transferred to 1.5 ml microtubes containing
1 ml ultra-pure water. Cell constructs (n = 3) were cry-
opreserved at −80 ◦C for further analysis. Prior to ALP
quantification, the samples were thawed and sonicated
for 15 min.
Alkaline phosphatase (ALP) activity was measured by
the specific conversion of p-nitrophenol phosphate (pNpp;
Sigma) into p-nitrophenol (pNp). The enzymatic reaction
was set up by mixing 100 ml of the sample with 300 ml of
substrate buffer containing 1 M diethanolamine HCl, pH
9.8, and 2 mg/ml pNp. The solution was further incubated
at 37 ◦C for 1 h and the reaction was stopped by adding a
solution containing 2 M NaOH and 0.2 mM EDTA. The OD
was determined at 405 nm. A standard curve was made
using pNp values in the range 0–20 µM/ml.
2.4. In vivo cranial defect in nude mice
Athymic nude mice, 7 weeks old (Harlan, Jerusalem,
Israel) were used to examine the healing of cranial crit-
ical size bone defects in response to transplants in the
defects according to the method described previously
(Gupta et al., 2008). All procedures involving the use of
animals were conducted in accordance with the guide-
lines of the Institutional Animal Care and Use Committee
of the Technion, Israel.
The in vitro cell constructs were cultured in osteogenic
inducing medium for 2 weeks prior to implantation. Each
scaffold was seeded with 1× 106 cells. All surgery was
performed under a protocol approved by the Animal Care
and Use Committee of the Technion, Israel.
Figure 1. Low magnification image of cranial defects imme-
diately after implantation. Cell constructs (Sc + MSCs) and
scaffolds without cells (Sc)
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Figure 2. SEM micrographs of general view (a) and magnified view (b) of chitosan–PBS (50% wt) salt-leaching scaffolds
Figure 3. Representative 2D µCT image (a) and 3D µCT image (b) of the scaffold obtained from the sequence of 2D sections
Two bilateral critical-size circular defects (5 mm diam-
eter ×1 mm thick) were created using a hand drill and
trephine bit in the parietal bones of the skull on either side
of the sagittal suture line (Figure 1). Care was taken not to
damage the sagittal suture or to interrupt the dura mater
beneath the bone. During the procedure, sterile saline was
dripped over the drilling site in order to avoid extensive
heating and to protect the brain. Figure 1 illustrates the
location of the defects in the mice crania. Surgery was
performed under general anaesthesia (xylazine:ketamine,
1:1 solution in saline) by intraperitoneal injection.
Scaffolds were randomly implanted into the defects and
divided into two experimental groups, which received the
following implants: scaffolds seeded and cultured for
2 weeks with 1× 106 hBMSC and scaffold without cells.
A total of six nude mice were used and 12 cranial defects
were created. Animals were kept under aseptic conditions.
After 8 weeks post-surgery, animals were euthanized and
crania were removed, cleaned and fixed immediately in
formalin for 24 h, to be analysed by µCT analysis. Briefly,
the mice crania (with or without cells) were also anal-
ysed, using a high-resolution µCT Skyscan 1072 scanner
(Skyscan, Kontich, Belgium). Six specimens were scanned
in high resolution mode, using a pixel size of 19.13 µm
and an integration time of 1.7 ms. The X-ray source was
set at 91 keV of energy and 110 µA of current. For all the
scanned specimens, representative datasets of 1023 slices
were transformed into binary, using a dynamic threshold
of 255-120 to distinguish bone from polymeric material.
Table 1. Porosity, pore size and interconnectivity of
chitosan-PBS scaffolds
Porosity (%) Pore size (mm) Interconnectivity (%)
59.0± 11.4 144.9± 33.4 60.9± 25.7
These datawere used formorphometric analysis (CT Anal-
yser v 1.5.1.5, SkyScan). 3D virtualmodels of themice cra-
nia were created, visualized, and registered using image-
processing software (ANT 3D Creator v 2.4, SkyScan).
2.5. Statistical analysis
The results of MTS and ALP are expressed as mean ±
standard deviation (SD), with n = 3 for each group. The
statistical significance of differences was determined using
the Student’s t-test multiple comparison procedure at a
confidence interval of 95% (p < 0.01).
3. Results and discussion
3.1. Characterization of scaffolds
SEM micrographs of the porous scaffolds are presented
in Figure 2; Figure 2a shows the morphology of scaf-
folds 4 mm in diameter and 1 mm thick. Previous studies
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Figure 4. SEM micrographs of the cell-seeded scaffolds cultured under osteogenic induction, after 1 (a, b), 2 (c, d) and 3 (e,
f) weeks
Figure 5. Energy dispersive spectra (EDS) showing the presence of calcium (#) and phosphorus (∗) at the surface of the seeded
chitosan–PBS (a) and scaffolds without cells (control) (b) after 3 weeks under osteogenic culture conditions
Figure 6. MTS viability assay of cell constructs and cultured
chitosan–PBS scaffolds following 3 h (0 days), 7, 14 and 21 days
after cell seeding. Results are expressed as mean ± standard
deviation (SD), with n = 3 for each bar. ∗Significant difference
(p < 0.01) between testing conditions as a function of time
Figure 7. Alkaline phosphatase activity of hBMSCs cultured on
the scaffolds after 1, 2 and 3 weeks under osteogenic induction.
Results are expressed as mean ± SD, with n = 3 for each
bar. ∗Significant difference (p < 0.01) between conditions as
a function of time
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Figure 8. Micro-CT analysis of calvaria defects in nude mice. Images show the endpoint result, after 8 weeks, of bone healing
upon implantation of scaffolds in the cranial defect of nude mice. E, empty; Sc, scaffold alone; Sc + MSCs, scaffolds with hBMSCs
pre-cultured in vitro in osteogenic medium
(Alves da Silva et al., 2010; Costa-Pinto et al., 2008;
Oliveira et al., 2008) demonstrated that these scaffolds
had adequate porosity (Figure 2b) to allow extensive cell
proliferation.
For a detailed characterization of the scaffolds’ inter-
nal structure, µCT studies were conducted. Images of the
region of interest were acquired and transformed into
binary images (figure not shown). For all scaffolds, a
dynamic threshold in the grayscale value range 255–150
was used to distinguish polymer material from pore voids.
Individual two-dimensional (2D) analysis of the binary
images (with a circle of interest of 4.5 mm2) was obtained
from the scaffold cross-sections, consisting of 300 slices
(Figure 3) and used for morphometric analysis (Table 1).
The overall porosity of approximately 60% was consistent
with the amount of leachable NaCl particles used in the
preparation of the scaffolds. The average pore size was
lower than expected, since the selected range of NaCl
particles used was in the range 250–500 µm. However,
the mixing in the solid phase and the subsequent com-
pression moulding may have caused significant reduction
of the leachable particles, and consequently of the pore
size. The level of interconnectivity indicated that most of
the pores were open and probably allowed cell infiltration
into the scaffolds’ inner pores.
3.2. In vitro cell culture studies
3.2.1. Scanning electron microscopy (SEM)
SEM analysis showed that cells presented a great affinity
to the scaffold surfaces, which was evident by the mas-
sive cell adhesion at the surface of the scaffolds (Figure 4).
Previous results also showed this cell behaviour at the sur-
face of similar scaffolds (Costa-Pinto et al., 2009). After
only 1 week of culture (Figure 4a, b), remarkable cell
proliferation on the 3D structures was already visible.
In the second week of culture a multilayer of cells cov-
ered the surfaces of the three-dimensional (3D) scaffold
(Figure 4c, d). After 3 weeks of culture, it was visible that
cell proliferation further developed into a dense multilay-
ered cell structure (Figure 4e). Furthermore, there was
clear presence of Ca–P deposits (Figure 4f) correspond-
ing to the produced mineralized ECM that was visible
at higher magnifications. These results were confirmed
by energy dispersive spectroscopy (EDS) analysis per-
formed in samples cultured for up to 21 days (Figure 5).
Unseeded scaffolds (kept immersed in osteogenic medium
for the same period of time) were used as controls of EDS
analysis. The presence of Ca and P peaks in the spectrum
confirmed the presence of Ca and P elements at the sur-
face of the cell-seeded scaffolds, which indicated that the
cells were producingmineralized ECM and thus confirmed
osteogenic differentiation after 21 days of culture.
3.2.2. Cell viability (MTS)
A cell viability assay (MTS) was used to assess the activ-
ity of the cells over time. The results demonstrated that
hBMSCs seeded onto chitosan–PBS scaffolds were able to
reduce the MTS substrate and progressively increased its
metabolic activity during the time of culture (Figure 6).
The obtained optical density values showed a significant
increase after 21 days of culture. These results were cor-
roborated by SEM images (Figure 4), with an increase of
cell colonization over time. Furthermore, the presence of
such active cells just after seeding (time 0) corresponded
to a great seeding efficacy, which was due to the prefer-
ence of the cells for these scaffolds instead of the tissue
culture plate. These results were in accordance with pre-
vious results using different cells cultured onto similar
scaffolds (Alves da Silva et al., 2010; Costa-Pinto et al.,
2008, 2009; Oliveira et al., 2008).
3.2.3. Alkaline phosphatase activity (ALP)
The ALP activity of human MSCs cultured onto the scaf-
folds did not follow the typical trend of this marker of
osteogenic differentiation, as it was demonstrated after
21 days (Figure 7). After this time point, a significant
increase in ALP activity was observed (Figure 7). Usually,
ALP reaches a peak at an earlier time point. However,
the presence of visible deposits of mineralized matrix
after 21 days (SEM images, cell viability and EDS results)
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suggested that the cells were viable and continued to
deposit matrix, thereby indicating the cells’ osteogenic
differentiation.
3.3. In vivo cranial defect in nude mice
After the in vitro studies, the following step involved the
in vivo validation, using a suitable animal model. For that,
cell constructs were tested using a critical sized cranial
defect. Briefly, we planned a study using the critical size
calvaria bone defect in nude mice, using chitosan–PBS
scaffolds and human cells. In this way, we were able
to test both the viability of the 3D cell construct in vivo
and the ability of those constructs to regenerate bone
tissue. Cranial reconstruction represents a unique model
to study bone regeneration, mainly because the calvaria
is an anatomical area under limited mechanical stress,
quite unlike the axial skeleton, which is subjected to long
periods of compressive load (Mankani et al., 2006). We
used a 5 mm diameter defect, based on previous data
found in the literature, showing that adult nude mice
did not demonstrate significant calvaria bone healing in
defects of 3, 4 and 5 mm diameter (Gupta et al., 2008).
The scaffolds’ diameter was optimized to enable some
swelling before implantation. Previous studies have
shown that these scaffolds have approximately 21% of
water uptake. Based on these findings, we have implanted
scaffolds 4.5 mm in diameter to match the size of the
defect at the time of implantation.
Bone formation was evaluated by µCT. This method-
ology is a low radiation and non-invasive method for
studying the structure of bone samples. It can generate
high-resolution images and provide accurate quantitative
analysis of the bone structure parameters (Tuan and
Hutmacher, 2005).
Bone possesses some self-healing capacity. However,
there is a limit to the size of bone fractures and defects that
can be self-repaired. This limit is designated the ‘critical
size defect’ (An and Freidman, 1998; Wu et al., 2010) and
will not heal completely during the lifetime of the patient.
For large bone defects, medical intervention is often nec-
essary to repair the bone. In this study we have used
hBMSCs cultured onto chitosan-based scaffolds in order
to assess the ability of these tissue-engineered constructs
to induce bone regeneration in nude mice cranial critical
size defects. To our knowledge, there are few studies doc-
umenting the use of xenogeneic grafts (i.e. human cells
and scaffolds) in the athymic nude mouse model (Cowan
et al., 2004; De´gano et al., 2008; Kim et al., 2006; Meinel
et al., 2005). We used nude mice in order to study the
osteogenic potential of the hBMSCs seeded and cultured
on chitosan–PBS scaffolds when implanted in a critical
size defect. The µCT results suggested that after 8 weeks
of implantation, cell constructs promoted bone regenera-
tion of the calvaria critical-size defect (Figure 8). The µCT
images also supported the enhanced bone ingrowth in
scaffolds cultured with MSCs. Some of the images clearly
show an almost complete healing of the defect (Figure 8b,
c). These findings are in accordance with previous results
where scaffolds seeded with pre-induced osteogenic MSCs
enhanced bone regeneration in critical size defect when
the same animal model was used (Meinel et al., 2005).
Scaffolds per se were able to induce some bone regen-
eration/ingrowth (Figure 8c). New bone formation could
be due to invading reparative cells from the dura or
from adjacent host tissues. The selected implantation
time seemed to be adequate for assessing the complete
bone healing at the site defect, as shown in Figure 8c.
Further studies need to be addressed using these scaffolds
without cells, in immunocompetent animals, to confirm
the tissue regeneration ability of chitosan–PBS scaffolds.
4. Conclusions
In the present study, chitosan–poly(butylene succinate)
scaffolds were successfully produced by melt-based com-
pression moulding followed by salt leaching. The microar-
chitecture of the scaffolds was assessed by SEM and µCT,
revealing a fully porous and interconnected 3D structure.
In vitro cell culture studies using hBMSCs have shown
properties compatible with bone-engineering applica-
tions. The cells evidenced high levels of viability as a
function of culture time and well correlated with SEM
images that showed extensive cell colonization of the
scaffolds. The produced ECM showed the presence of
Ca and P elements, detected in EDS spectra of the cul-
tured scaffold surfaces, which confirmed mineralization.
Successful bone regeneration was achieved using critical
size defects in the calvaria of nude mice, with prominent
results for the in vitro cell construct compared to the
scaffold without cells.
The combination of good biological performance of
hBMSCs cultured onto chitosan-based scaffolds and the
ability to regenerate bone tissue in a critical size defect sig-
nificantly expands previous evidence that these materials
can and will have a role to play in bone tissue-engineering
strategies.
This study evidenced very positive results that highlight
the possibility of chitosan–PBS–hBMSC constructs to be
used as implants for non-load-bearing bone defects.
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